VANCOUVER, BRITISH COLUMBIA–(Marketwire – Feb. 8, 2010) - EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) (”EnWave”, or the “Company”) is pleased to announce the completion of successful animal feeding trials with Neova Technologies Inc. of Abbotsford, B.C., a division of Bioseutica, plc. The study used EnWave’s Radiant Energy Vacuum (”REV”) dehydration technology to dry encapsulated lysozyme, a natural anti-microbial enzyme, to determine whether it can be used as a replacement for antibiotics in chicken feed. The trials showed that the dried, encapsulated enzyme permitted the same level of infection resistance as is normally obtained with pharmaceutical antibiotics. Countries around the world have been looking for ways to eliminate the routine usage of antibiotics in animal feed in order to reduce the perceived risk of anti-microbial resistance (”AMR”) in human and animal populations. AMR is a serious co